Number of Clinical Trials 2023
Explore the number of clinical trials conducted in various countries; critical for medical research and innovation.
Newer data is available: Number of Clinical Trials by country 2024 →
Where does your country rank? Pick it to see its position.
Related Health statistics
More ↓Interactive Map
Complete Data Rankings
Analysis: These countries represent the highest values in this dataset, showcasing significant scale and impact on global statistics.
- #149
Suriname
- #148
Somalia
- #147
San Marino
- #146
New Caledonia
- #145
Myanmar
- #144
Morocco
- #143
Mongolia
- #142
Martinique
- #141
Latvia
- #140
Laos
Context: These countries or territories have the lowest values, often due to geographic size, administrative status, or specific characteristics.
Insights by country
Turkey
In 2023, Turkey ranks #2 globally with a total of 1,940 clinical trials. This significant number is only surpassed by the United States, highlighting Turkey's prominence in clinical research within the region. The country's strategic location, robust healthcare infrastructure, and a diverse patient population facilitate rapid recruitment for trials, making it an attractive destination for pharmaceutical companies and researchers.
Indonesia
In 2023, Indonesia ranks #30 globally with a total of 107 clinical trials. This places Indonesia above the regional average, reflecting its growing role in the Southeast Asian clinical research landscape. The country's diverse population and increasing investment in healthcare infrastructure drive the expansion of clinical trials, alongside supportive government policies aimed at fostering medical research.
Iraq
In 2023, Iraq ranks #44 globally with a total of 38 clinical trials. This number is relatively low compared to neighboring countries like Iran, which has a significantly higher number of trials. The limited clinical trial activity in Iraq can be attributed to ongoing political instability, a challenging healthcare infrastructure, and the need for improved regulatory frameworks to attract more research investment.
Bahrain
Bahrain ranks #106 globally with a total of 2 clinical trials in 2023. This figure is significantly lower than many of its regional peers, reflecting a limited capacity for clinical research compared to countries like Saudi Arabia, which has a more developed healthcare infrastructure.
The low number of clinical trials in Bahrain can be attributed to its small population and a nascent research ecosystem, which faces challenges in attracting international pharmaceutical companies and research institutions. Additionally, regulatory frameworks and funding for clinical research are still evolving, impacting the overall trial landscape.
Luxembourg
In 2023, Luxembourg ranks #101 globally with a total of 3 clinical trials. This figure is notably low compared to neighboring countries like Belgium, which has a more robust clinical research landscape. The limited number of clinical trials in Luxembourg can be attributed to its small population size and a focus on niche sectors within the healthcare industry, which may restrict broader clinical research initiatives.
Latvia
In 2023, Latvia ranks #139 globally with a total of 1 clinical trial. This places Latvia at the lower end of clinical trial activity, especially when compared to neighboring countries like Estonia, which has a more robust clinical research infrastructure. The limited number of clinical trials in Latvia can be attributed to its smaller population and a less developed healthcare research ecosystem, which may hinder the country's ability to attract significant research investments.
Laos
In 2023, Laos ranks #138 globally with a total of 1 clinical trial. This places the country near the bottom in comparison to its regional neighbors, many of which have significantly higher numbers of clinical trials. The low figure can be attributed to Laos's limited research infrastructure, a small population, and ongoing challenges in healthcare funding and policy development.
Finland
In 2023, Finland ranks #38 globally with a total of 61 clinical trials. This figure is notable considering that Finland's clinical trial activity is influenced by its robust healthcare system and strong emphasis on research and development. Additionally, the country's favorable regulatory environment and collaboration between public and private sectors enhance its attractiveness for clinical research.
New Caledonia
In 2023, New Caledonia ranks #143 globally with a total of 1 clinical trial. This figure is notably low compared to neighboring Australia, which has a significantly higher number of clinical trials due to its robust healthcare infrastructure and research funding. The limited number of clinical trials in New Caledonia can be attributed to its small population and geographic isolation, which restricts access to larger research networks and funding opportunities.
South Korea
In 2023, South Korea ranks #12 globally with a total of 402 clinical trials. This figure is notably higher than the global average, showcasing the country's robust position in clinical research. South Korea's advanced healthcare infrastructure, significant investment in biotechnology, and a strong emphasis on innovation contribute to its high number of clinical trials, positioning it as a leader in the Asia-Pacific region.
Analysis & Context
In 2023, the United States leads the world with the highest Number of Clinical Trials, tallying at 6712. Globally, the range of clinical trials spans from a minimum of 1 to the maximum observed in the U.S., with data collected from 149 countries. The average number of clinical trials conducted worldwide stands at 145.22, while the median is 11.
Global Disparities in Clinical Trials
The stark contrast in the Number of Clinical Trials between countries highlights significant disparities in medical research capacity. While the United States is at the forefront with 6712 trials, countries like Cabo Verde, Guatemala, and Morocco report only 1 trial each. This disparity can often be attributed to differences in economic capabilities, healthcare infrastructure, and policy priorities. Developed nations tend to have more robust healthcare systems and greater investment in research and development, enabling a higher volume of clinical trials.
For instance, China, with 1661 trials, is rapidly expanding its clinical research capacity, supported by governmental initiatives and significant investments in biotechnology. Similarly, France and Germany, with 1213 and 477 trials respectively, benefit from strong healthcare systems and long-standing traditions of scientific research.
Geopolitical and Economic Influences
The distribution of clinical trials is heavily influenced by geopolitical and economic factors. Countries with large pharmaceutical industries, such as the United States and Germany, naturally conduct more trials due to the presence of numerous research organizations and access to funding. In contrast, nations with smaller economies or those experiencing political instability may struggle to initiate and sustain clinical research activities.
Turkey and Egypt have shown significant activity with 1940 and 1146 trials respectively, reflecting their strategic emphasis on developing healthcare sectors. These countries are leveraging their geopolitical positions to attract international collaborations and investments in clinical trials.
Year-over-Year Trends and Movers
The year-over-year changes in the Number of Clinical Trials reveal notable trends. China experienced the largest increase, adding 304 trials, a growth of 22.4%. This surge is likely driven by its strategic focus on becoming a global leader in medical research and development. Similarly, Turkey and Egypt saw substantial increases of 238 and 197 trials, respectively, emphasizing their growing roles in regional healthcare innovation.
Conversely, the United States witnessed a decrease of 114 trials, a 1.7% reduction. This decline, along with decreases in France (-86 trials) and the United Kingdom (-81 trials), may reflect shifting research priorities, regulatory challenges, or economic constraints impacting the number of new trials.
Strategic Implications for Global Health
The distribution and trends in the Number of Clinical Trials have profound implications for global health. Countries with higher numbers of trials, like the United States and China, are positioned to lead in medical innovations, potentially shaping global healthcare practices and policies. Meanwhile, nations with fewer trials may face challenges in accessing cutting-edge treatments and participating in the global research ecosystem.
By understanding these patterns, policymakers and healthcare leaders can identify opportunities for collaboration, investment, and policy development to enhance their countries' research capabilities. Such strategic initiatives are crucial for addressing global health challenges and ensuring equitable access to medical advancements.
Frequently Asked Questions About Number of Clinical Trials in 2023
Which country conducted the most clinical trials in 2023?
The United States conducted the most clinical trials in 2023, with a total of 6,712 trials.
What is the average number of clinical trials conducted per country in 2023?
The average number of clinical trials conducted per country in 2023 is 145.
Which country conducted the fewest clinical trials in 2023?
Cabo Verde conducted the fewest clinical trials in 2023, with only 1 trial.
What is the median number of clinical trials conducted by countries in 2023?
The median number of clinical trials conducted by countries in 2023 is 11.
How many countries conducted only 1 clinical trial in 2023?
Ten countries conducted only 1 clinical trial in 2023, including Cabo Verde, Guatemala, and Martinique.
What is the range of clinical trials conducted across countries in 2023?
The range of clinical trials conducted across countries in 2023 is from 1 trial in Cabo Verde to 6,712 trials in the United States.
Data Source
Number of clinical trials | ClinicalTrials.gov via Our World in Data
Data produced by ClinicalTrials.gov, compiled and published by Our World in Data as "Number of clinical trials".
Visit Data SourceCite this page
Geo Factbook. (n.d.). Number of Clinical Trials by Country, 2023. Retrieved November 16, 2026, from https://geofactbook.com/fact/number-of-clinical-trials/2023
The figures on this page come from Number of clinical trials | ClinicalTrials.gov via Our World in Data. For academic work, cite the original source as well.
›Embed this ranking on your site
Free to embed with attribution. Shows the top 10 countries and links back to the full ranking.